Vitamin Blue Financials
| VTMB Stock | USD 0.0001 0.00 0.00% |
Vitamin |
Understanding current and past Vitamin Blue Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vitamin Blue's financial statements are interrelated, with each one affecting the others. For example, an increase in Vitamin Blue's assets may result in an increase in income on the income statement.
Please note, the presentation of Vitamin Blue's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vitamin Blue's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vitamin Blue's management manipulating its earnings.
Vitamin Blue Stock Summary
Vitamin Blue competes with Timken, Weyco, Acme United, Inter Parfums, and Rivian Automotive. Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US92849G1067 |
| Business Address | 1005 West 18th |
| Sector | Consumer Cyclical |
| Industry | Leisure |
| Benchmark | Dow Jones Industrial |
| Website | www.vitaminblue.com |
| Phone | 949 645 4592 |
| Currency | USD - US Dollar |
Vitamin Blue Key Financial Ratios
Vitamin Blue's financial ratios allow both analysts and investors to convert raw data from Vitamin Blue's financial statements into concise, actionable information that can be used to evaluate the performance of Vitamin Blue over time and compare it to other companies across industries.| Return On Asset | -1.4 | |||
| Beta | 48.49 |
Vitamin Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vitamin Blue's current stock value. Our valuation model uses many indicators to compare Vitamin Blue value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vitamin Blue competition to find correlations between indicators driving Vitamin Blue's intrinsic value. More Info.Vitamin Blue is rated first in return on asset category among its peers. It is rated first in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vitamin Blue by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vitamin Blue's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Vitamin Blue Systematic Risk
Vitamin Blue's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vitamin Blue volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Vitamin Blue correlated with the market. If Beta is less than 0 Vitamin Blue generally moves in the opposite direction as compared to the market. If Vitamin Blue Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vitamin Blue is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vitamin Blue is generally in the same direction as the market. If Beta > 1 Vitamin Blue moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |